• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cota Partners with Miami Cancer Institute to Fuel Personalized Cancer Treatment

by Fred Pennic 01/03/2018 Leave a Comment

Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients

Cota, a healthcare data and analytics company bridging precision medicine to population health has announced their latest collaboration with Baptist Health South Florida to advance cancer treatment and clinical research at the new Miami Cancer Institute (MCI). The partnership will further support the organization’s initiative of precision medicine, improve care delivery and ensure the most effective treatment for every type of cancer.

MCI will leverage Cota’s Provider Solution to identify unwanted variances at the physician and practice level and feed data sets through the Cota Nodal Address. This process will bring MCI one step closer to personalized medicine by generating critical insights to improve quality and outcomes, increase oncology margins in fee-for-service and value-based care and assist practices looking to transition to VBC. This collaboration will also help Cota bolster its real-world evidence database and follows their recent partnership with the Memorial Sloan Kettering Cancer Center (MSK).

The Cota Provider solution is an end-to-end oncology analytics suite comprised of real-world analytics, decision support and value based tracking. Leveraging the patented Cota Nodal AddressTM (CNA), a precision patient classification system, and Cota Real-World Evidence (RWE), the industry’s leading collection of oncology patient data, the Cota Provider solution improves quality and outcomes in cancer care, increases oncology margins in fee-for-service and value-based arrangements and assists practices looking to transition to value-based care.

“Miami Cancer Institute is committed to combining the latest technology and innovation to enable personalized medicine in cancer care. That is why we selected Cota, a market leader in data and analytics. By using their Provider Solution and CNA we’ll be able to generate critical insights from our data to continually improve the quality of care we deliver to our patients,” said Michael J. Zinner, M.D., founding chief executive officer and executive medical director of Miami Cancer Institute.

RELATED:   Meaningful Use of Genomics Requires Informatics Beyond EMRs

Tagged With: COTA, Personalized Cancer Medicine, Precision Medicine

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Paging Dr. Siri: How AI-Integrated Digital Health Could One Day Diagnose Your Melanoma
HealthTap Provides Access for those in need to Doctor Consultations Free of Charge »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • CVS Health Launches Senior Medical Alert System, Symphony

    CVS Health Launches Senior Medical Alert System, Symphony

    ... more
  • Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health

    Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

    ... more
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup

    MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process

    ... more
  • Heritage Group

    Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021 Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • How-COVID-19-Reshaped-Healthcare-Consumerism-4-Key-Trends-to-Know-for-2021 How COVID-19 Reshaped Healthcare Consumerism & 4 Key Trends to Know for 2021
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |